0% found this document useful (0 votes)
90 views3 pages

COPD Treatment and Assessment Guidelines

This document provides guidelines for treating COPD in 4 stages based on severity. It recommends using spirometry to diagnose COPD and assess severity based on FEV1 levels. Treatment involves non-drug approaches like smoking cessation and vaccinations as well as drug therapies starting with bronchodilators alone or in combination based on symptoms and exacerbation risk. It provides details on different classes of bronchodilators including anticholinergics, beta-agonists, and phosphodiesterase inhibitors and how to use various inhaler devices properly.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
90 views3 pages

COPD Treatment and Assessment Guidelines

This document provides guidelines for treating COPD in 4 stages based on severity. It recommends using spirometry to diagnose COPD and assess severity based on FEV1 levels. Treatment involves non-drug approaches like smoking cessation and vaccinations as well as drug therapies starting with bronchodilators alone or in combination based on symptoms and exacerbation risk. It provides details on different classes of bronchodilators including anticholinergics, beta-agonists, and phosphodiesterase inhibitors and how to use various inhaler devices properly.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd

Patient Recommended Tx Assessment Escalation

Group

A A bronchodilator Sx controlled→ Continue initial tx


SAMA or SAMA PRN Sx not well controlled→ Try a different class of
LABA or LAMA bronchodilator as monotx

B LAMA or LABA Persistent sx→ LAMA + LABA

C LAMA (preferred because has a greater impact on Further exacerbations→ LAMA + LABA or LABA + ICS
exacerbation rates)

D LAMA + LABA or LABA + ICS Persistent sx and further LAMA + LABA + ICS
exacerbations→

CHAPTER 36 COPD
● Spirometry is required to assess lung function and ● Non-Drug Tx:
make a dx for COPD ○ Smoking cessation is the only method to
○ Post bronchodilator FEV1/FVC<0.70 slow the progression of COPD
confirms a dx of COPD ○ Annual flu vaccine and pneumococcal
○ Gold 1: mild; FEV1 >80% vaccinations dec the risk of hospitalizations
○ Gold 2: moderate; FEV1 50-80% ○ Assess inhaler technique and adherence to
○ Gold 3: severe; FEV1 30-50% improve outcomes
○ Gold 4: very severe; FEV1 <30% ○ Long term oxygen tx for patients with
● mMRC dyspnea scale: assess breathlessness and severe resting hypoxemia inc survival
scores range from 0 (only breathless with exercise) ● Drug tx: only help with sx and prevent
to 4 (too breathless to leave the house/do normal complications
daily activities) ○ Each tx is personalized based on combined
● CAT score: assesses all sx; scores range from 0-40%; assessment
higher scores→ worse sx ○ First line: bronchodilator
● >2 exacerbations/year→ frequent exacerbators ○ SABAs & SABAs added PRN
● Combined Assessment: sx assessment and risk of ○ If regular use is required, LAMAs or LABAs
exacerbations drive tx options should be used
○ Combining different bronchodilators from
different classes may improve efficacy and
dec SE
○ Long term monotx with PO or ICS is not
recommended, but ICS may be added to
LABA tx or LAMA/LABA tx in moderate-
severe COPD
■ ICS may cause pneumonia, but
overall improves sx, lung ftn, QoL,
and reduces exacerbation
frequency
○ PDE-4 inhibitors are used in most severe
cases
○ Theophylline can only be used if no other
options
● Exacerbations: treated with a SABA with/without a ○ Indacaterol (Arcapta Neohaler) 75 mcg
SAMA + an IV/PO systemic steroid capsule
○ If there is inc sputum purulence, inc sputum ■ DPI: 1 capsule daily
volume, inc dyspnea, or mechanical ○ Olodaterol (Striverdi Respimat)
ventilation i s needed, abx should be used ■ MDI: 2 inh daily
for 5-10 days ● Phosphodiesterase Inhibitor: Inhibit PDE-4 to inc
● Muscarinic Antagonists/Anticholinergics: block cAMP levels leading to dec lung inflammation
constricting action of Ach at M3 muscarinic ○ Should always be used in combo with at
receptors in BSM least one long acting bronchodilator
○ SE: dry mouth, URTI, cough, bitter taste ○ Reserved for very severe COPD, chronic
○ Avoid spraying in eyes bronchitis, and hx of exacerbation
○ Do not swallow the capsules in DPIs ○ Roflumilast: (Daliresp) 500 mcg PO QD
● SAMAs: ■ CI: moderate to severe hepatic
○ Ipratropium bromide: impairment
■ Atrovent HFA (17 mcg/inh) ■ SE: diarrhea, weight loss
● MDI: 2 inh QID ■ Major 3A4 and 1A2 substrate
● Neb: 0.5 mg TID-QID ● Respimat:
■ Combivent Respimat (20 mcg ○ Turn the blear base until it clicks
ipra/100 mg alb/inh) ○ Turn head away and breathe out slowly,
● MDI: 1 inh QID fully
■ Combivent Respimat Neb (0.5 mg ○ Take a slow deep breath and press the dose
ip/2.5 mg alb/3 mL) release button as you breathe in slowly
● Neb: 3 mL QID ○ Hold your breath as long as possible, up to
● LAMAs: 10 sec
○ Aclidinium (Tudorza PressAir): 400 mcg/inh ○ Discard 3 months after cartridge is inserted
■ DPI: 1 inh BID ○ Priming:
○ Glycopyrrolate: 15.6 mcg/inh ■ Turn it until you hear a click
■ DPI: 1 capsule BID ■ Point towards the floor and push
○ Tiotropium: the dose release button
■ Spiriva Handihaler (18 mcg capsule) ■ Repeat until a spray is visible
1 capsule QD (requires 2 puffs) ■ When a spray is visible, repeat 3x
■ Spiriva Respimat (2.5 mcg/inh) MDI: ■ If not used in >3 days prime again
2 inh QD by releasing one spray to the
○ Umeclidinium (Incruse Ellipta): 62.5 ground
mcg/inh ■ If not used for >21 days, prime like
■ DPI: 1 inh QD initial use
● Long acting beta-2 agonists: LABAs should be used ○ Clean with a damp cloth or tissue weekly.
as monotx in COPD only ● Handihaler:
○ CI: status asthmaticus, acute episodes of ○ Remove the capsule and insert into the
asthma or COPD, monotx in tx of asthma chamber
○ SE: nervousness, tremor, tachycardia, ○ Close the mouthpiece firmly until you hear
palpitations, cough, hyperglycemia, dec K a click
○ Do not swallow the capsules by mouth ○ Press the green button once until it is flat
○ Salmeterol: (serevent Diskus) 50 mcg/inh against the base then release. Do not shake
■ DPI: 1 inh BID ○ Turn head away and breathe out fully
○ Formoterol: (Perforomist) 20 mcg/2 mL neb ○ Breathe in deeply and fully. You should feel
soln it vibrate
■ Neb: 20 mcg BID ○ Hold breath for a few seconds then breathe
normally
○ To get full dose, you must inhale twice from ○ Breathe out
each capsule. Repeat last two steps ○ The chamber should be empty. If not, inhale
breathing out fully again and breathing in again
deeply and fully through the inhaler. ○ Remove capsule by tipping it out
○ Tip out the used capsule after two ○ Clean with a dry towel
inhalations into a trashcan.
○ Clean by running under warm water and
pushing green button to rinse piercing
needle and chamber under water.
○ Make sure any powder build up is gone.
○ Let air dry for 24 hours before use.
● Tudorza Pressair:
○ Hold inhaler with mouthpiece facing you
and the green button face up. Before
putting in your mouth, press the green
button all the way down then release.
○ Check the control window. Green means
go.
○ Breathe out completely away from the
inhaler
○ Breathe in until you hear a click sound and
keep breathing in to get a full dose
○ Hold your breath for as long as you can
○ Breathe out slowly through your nose
○ Check the control window. Red means you
got the full fose.
○ Clean by wiping with a dry paper towel
● Ellipta:
○ Slide the cover down until you hear a click.
○ Turn your face away and breathe out fully.
○ Take one long, deep, steady breath through
your mouth
○ Do not block the air vent with your fingers
○ Hold breath for 3-4 sec or as long as
comfortable
○ Breathe out slowly and gently
○ Rinse mouth out if ICS
○ Clean with dry tissue before you close the
cover.
● Neohaler:
○ Remove a capsule and place in the chamber
○ Close the inhaler until you hear a click
○ Hold inhaler upright. Push both buttons
down until you hear a click.
○ Release buttons and breathe out fully, away
from inhaler.
○ Hold inhaler with buttons to the side in your
mouth. Breathe in rapidly and deeply until
you hear a whirring sound

You might also like